Figures & data
Table I. Baseline variables mean values and the number of individuals (n) in each group who had this variable measured at baseline. Variable are shown separately for individuals with an ESR <6 and ≥6.
Table II. Different quartiles of hematocrit, the number of men (n) within each quartile and the level of haematocrit with the standard deviation (SD). The different quartiles are divided into groups with erythrocyte sedimentation rate (ESR) below and above median (6 mm/h).
Figure 1. Kaplan-Meier curves describing risk development among 488, grouped by quartiles of hematocrit (Q1-Q4).
![Figure 1. Kaplan-Meier curves describing risk development among 488, grouped by quartiles of hematocrit (Q1-Q4).](/cms/asset/f2545bdc-4d68-4b76-a482-4f2d0b43fe96/icdv_a_417297_f0001_b.gif)
Figure 2. Kaplan-Meier curves describing risk development among 265 men with erythrocyte sedimentation rate above 6 mm/h, grouped by quartiles of hematocrit (Q1–Q4).
![Figure 2. Kaplan-Meier curves describing risk development among 265 men with erythrocyte sedimentation rate above 6 mm/h, grouped by quartiles of hematocrit (Q1–Q4).](/cms/asset/d8816180-07b6-4b7a-a9b2-764390c5d979/icdv_a_417297_f0002_b.gif)
Table III. Numbers of CV deaths in within each quartile (Q1Q4) of hematocrit and the adjusted hazard ratio (HR) compared to the quartile with the lowest hematocrit (Q1). Data are shown separately for individuals with an erythrocyte sedimentation rate (ESR) below and above median (6 mm/h).